EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Oct. 18, 2005--Esprit Pharma, Inc. today announced that it acquired exclusive North American rights to ESTRASORB(R) (estradiol topical emulsion) from Novavax, Inc. (NASDAQ:NVAX). A topical emulsion form of the naturally occurring hormone 17beta-estradiol, ESTRASORB is the first prescription topical emulsion for estrogen therapy.
